4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001599298-25-000106
Co-Chief Executive Officer acquired 74,545 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
DUGGAN ROBERT W · Co-Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-05-30 | Exercise or conversion : show line 1 in the form | +74,545 | $2.64 | $196,799 | 555,754,696 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-05-30 | Exercise or conversion : show line 2 in the form Stock Option (right to buy) | −74,545 | 0 | D |
Loading xslF345X05/wk-form4_1748897749.xml…